Feb 21, 2022 10:29 PM (GMT+8) · EqualOcean
Yin Weidong, chairman, President and CEO of China Kexing, said today that China Kexing will invest 10 billion yuan in the next five years to support basic research, innovative R & D and industrialization in the field of biomedicine and promote the development of China's biomedical industry. "China contributes almost 50% of the world's total vaccines," Yin Weidong said. "China's vaccines are not only vaccinated at home, but nearly 2 billion doses are vaccinated in different countries and regions around the world." Yin Weidong said that in addition to increasing its own R & D investment, part of the 10 billion yuan will be invested in cooperation with universities and scientific research institutes.